Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Insider Trades

Latest Guru Trades with PBE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT 21.70
PBE's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBE: 21.70 )
PBE' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 21.7

PEG 1.40
PBE's PEG is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBE: 1.40 )
PBE' s 10-Year PEG Range
Min: 0   Max: 1.4
Current: 1.4

0
1.4

Valuation & Return

vs
industry
vs
history

Business Description

Industry: »
Compare:KH, CTFO, GBG, URGP, GPRM » details
» More Articles for PBE

Headlines

Articles On GuruFocus.com
No related article found.

More From Our Partners
Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary Mar 31 2015 - ZACKS

More From Other Websites
Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary Mar 31 2015
3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary Mar 23 2015
ETFs for the Next Biotech Takeover Targets Mar 10 2015
POWERSHARES EXCHANGE TRADED FUND TRUST Financials Mar 06 2015
Biotech ETFs Sholud Like AbbVie’s bid for Pharmacyclics Mar 05 2015
Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary Feb 06 2015
‘Tis the Season for Biotech ETFs Jan 05 2015
3 Biotech ETFs Rally On Merger News Dec 08 2014
The Dominance of Health Care ETFs in One Chart Nov 20 2014
Biotech ETFs Prescribe New ETFs Oct 23 2014
Biotech ETFs Aren’t Waving the White Flag…Yet Oct 15 2014
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First... Oct 03 2014
The Complete Guide to Biotech ETFs Sep 30 2014
Five Forces that Will Shape the 21st Century Sep 29 2014
Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? Sep 09 2014
Interesting Biotech ETF Additions on the Way Sep 05 2014
Biotech ETFs Look to Build on Hot August Returns Sep 03 2014
Biotechnology ETFs Show Robust Health In August Sep 02 2014
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) Aug 27 2014
After Recent Surge, Are Biotech ETFs Back on Track? Aug 26 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK